These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 27348613

  • 1. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.
    Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.
    Am J Hematol; 2016 Oct; 91(10):989-94. PubMed ID: 27348613
    [Abstract] [Full Text] [Related]

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 3. A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.
    Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.
    Am J Hematol; 2016 Dec; 91(12):1181-1184. PubMed ID: 27538126
    [Abstract] [Full Text] [Related]

  • 4. Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
    Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.
    Am J Hematol; 2017 Dec; 92(12):1340-1348. PubMed ID: 28924974
    [Abstract] [Full Text] [Related]

  • 5. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K, Hoppe C, Mijovic A, Thein SL.
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [Abstract] [Full Text] [Related]

  • 6. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL.
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [Abstract] [Full Text] [Related]

  • 7. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V.
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [Abstract] [Full Text] [Related]

  • 8. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F, Bartolucci P, Habibi A.
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [Abstract] [Full Text] [Related]

  • 9. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Gerritsma J, Bongaerts V, Eckhardt C, Heijboer H, Nur E, Biemond B, van der Schoot E, Fijnvandraat K, SCORE consortium.
    Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
    Pirenne F, Yazdanbakhsh K.
    Blood; 2018 Jun 21; 131(25):2773-2781. PubMed ID: 29724898
    [Abstract] [Full Text] [Related]

  • 12. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M, Heidemann SM, Sarnaik AP, Meert KL, Sarnaik SA.
    J Pediatr Hematol Oncol; 1999 Jun 21; 21(1):70-3. PubMed ID: 10029818
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.
    King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM.
    Transfusion; 1997 Apr 21; 37(4):376-81. PubMed ID: 9111274
    [Abstract] [Full Text] [Related]

  • 15. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun 21; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 16. Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactions.
    Chadebech P, de Ménorval MA, Bodivit G, Jouard A, Pakdaman S, Lelong F, Habibi A, Galactéros F, Lecron JC, Pirenne F.
    Cytokine; 2020 Dec 21; 136():155259. PubMed ID: 32920319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM, Miller MJ, Chonat S, Stowell SR.
    Transfus Clin Biol; 2019 May 21; 26(2):94-98. PubMed ID: 30837199
    [Abstract] [Full Text] [Related]

  • 19. Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?
    Adkins BD, Sharma D, Eichbaum Q.
    Transfus Apher Sci; 2020 Apr 21; 59(2):102681. PubMed ID: 31831326
    [Abstract] [Full Text] [Related]

  • 20. Delayed hemolytic transfusion reaction in children with sickle cell disease.
    de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F.
    Haematologica; 2011 Jun 21; 96(6):801-7. PubMed ID: 21330322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.